Chemical Components Separation: Concepts, Evidence, and Outcomes

Area of Science:

• Abdominal Wall Reconstruction
• Hernia Surgery
• Minimally Invasive Surgery

Background:

• Ventral hernias with loss of domain present significant surgical challenges.
• Current abdominal wall reconstruction (AWR) techniques aim to increase abdominal wall capacity.
• Botulinum toxin A (BTA) is explored as an adjunct to AWR.

Purpose of the Study:

• To review the current literature on the use of BTA injection as an adjunct to AWR.
• To evaluate the efficacy and safety of preoperative BTA injection in ventral hernia repair.

Main Methods:

• A literature review identified 22 articles on BTA use in ventral hernia repair.
• Six primary studies reported on preoperative BTA injection.
• Treatment regimens varied in dosage (300-500 units) and timing (4 weeks pre-surgery).

Main Results:

• Computed tomography scans showed elongated, thinned abdominal muscles post-BTA injection.
• A decreased mean defect and hernia size was observed.
• Primary fascial closure was typically achieved, with potential improvement in postoperative pain.
• No adverse events related to BTA injection were reported.

Conclusions:

• Preoperative BTA injection is a promising adjunct for AWR, inducing abdominal wall laxity.
• It facilitates primary fascial repair in complex ventral hernias.
• Further research is needed to optimize dosage, timing, and patient selection for BTA use.